Buller Richard E 4

4 · Celcuity Inc. · Filed Aug 27, 2024

Form 4

Period: 2024-08-23

Director

Transactions

Sale
Common Stock
2024-08-23$16.95/sh−350$5,933→ 7,031 total(indirect: By Trust)

Holdings

Common Stock
1,079
Stock Option (right to buy)
(indirect: By Trust)
Exercise: $5.10Exp: 2030-05-14→ Common Stock (12,654 underlying)
12,654
Stock Option (right to buy)
(indirect: By Trust)
Exercise: $5.50Exp: 2031-05-12→ Common Stock (2,310 underlying)
2,310
Stock Option (right to buy)
(indirect: By Trust)
Exercise: $5.50Exp: 2032-05-17→ Common Stock (19,558 underlying)
19,558
Stock Option (right to buy)
(indirect: By Trust)
Exercise: $9.58Exp: 2033-05-15→ Common Stock (8,733 underlying)
8,733
Stock Option (right to buy)
Exercise: $14.83Exp: 2034-06-04→ Common Stock (6,522 underlying)
6,522
Stock Option (right to buy)
(indirect: By Trust)
Exercise: $5.50Exp: 2029-12-03→ Common Stock (4,555 underlying)
4,555

Footnotes (5)

[F1]Represents 1,079 shares of restricted stock for which risks of forfeiture lapse on April 30, 2025, or if earlier, the date of the Company's 2025 Annual Meeting of Stockholders.
[F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2023.
[F3]The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.
[F4]100% vested.
[F5]This Option will vest and become exercisable on April 30, 2025, or if earlier, the date of the Company's 2025 Annual Meeting of Stockholders.

Documents

1 file